Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis

Peptides

Volumn 52, Issue , 2014, Pages 11-18

  Qi, Ke Ke ^a   Wu, Jie ^a   Wan, Jing ^a   Men, Xiao Ming ^a   Xu, Zi Wei ^a  

^a INSTITUTE OF PLANT PROTECTION AND MICROBIOLOGY   (China)

Author keywords

Colitis; Dextran sulfate sodium; Ion exchange chromatography; PEGylation; Porcine glucagon like peptide 2

Indexed keywords

DEXTRAN SULFATE; GLUCAGON LIKE PEPTIDE 2; LYSINE; MACROGOL; MYELOPEROXIDASE; RESIN; SEPHAROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; DRUG HALF LIFE; DRUG STABILITY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INJURY SEVERITY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

MURINAE; MUS; SUS;

COLITIS; DEXTRAN SULFATE SODIUM; ION-EXCHANGE CHROMATOGRAPHY; PEGYLATION; PORCINE GLUCAGON-LIKE PEPTIDE-2;

ANIMALS; CHRONIC DISEASE; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GLUCAGON-LIKE PEPTIDE 2; MALE; MICE; MICE, INBRED BALB C; POLYETHYLENE GLYCOLS; SWINE;

EID: 84890493862     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.11.012     Document Type: Article

References (32)

1. K. Alavi, M.Z. Schwartz, J.P. Palazzo, and R. Prasad Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2 J Pediatr Surg 35 6 2000 847 851 (Pubitemid 30346176)
2. A. Amato, S. Baldassano, R. Serio, and F. Mulè Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release Am J Physiol Gastrointest Liver Physiol 296 3 2009 G678 G684
3. A. Au, A. Gupta, P. Schembri, and C.I. Cheeseman Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2 Biochem J 367 Pt 1 2002 247 254 (Pubitemid 35176912)
4. M.A. Benjamin, D.M. McKay, P.C. Yang, H. Cameron, and M.H. Perdue Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse Gut 47 1 2000 112 119 (Pubitemid 30430419)
5. D.G. Burrin, B. Stoll, and X. Guan Glucagon-like peptide 2 function in domestic animals Domest Anim Endocrinol 24 2 2003 103 122 (Pubitemid 36238323)
6. Y.Q. Cai, and P. Yue Separation of exenatide analongue mono-PEGylated with 40kDa polyethylene glycol by cation exchange chromatography J Chromatogr A 1218 2011 6953 6960
7. W.T. Chance, T. Foley-Nelson, I. Thomas, and A. Balasubramaniam Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2 Am J Physiol 273 2 Pt 1 1997 G559 G563
8. W.T. Chance, S. Sheriff, T. Foley-Nelson, I. Thomas, and A. Balasubramaniam Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: effects of glucagon-like peptide 2 Nutr Cancer 37 2 2000 215 222
9. L.A. Dieleman, M.J. Palmen, and H. Akola Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th 1 and Th2 cytokines Clin Exp immunol 114 1998 385 391 (Pubitemid 28539597)
10. D.J. Drucker, P. Ehrlich, and S.L. Asa Induction of intestinal epithelial proliferation by glucagons-like peptide 2 Proc Natl Acad Sci USA 93 1996 7911 7916 (Pubitemid 26277138)
11. D.J. Drucker, B. Yusta, R.P. Boushey, L. DeForest, and P.L. Brubaker Human [Gly2] GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis Am J Physiol Gastrointest Liver Physiol 276 1 1999 G79 G91
12. C.J. Fee, and J.M. Van Alstine PEG-proteins: reaction engineering and separation issues Chem Eng Sci 61 2006 924 939
13. A.P. Garrison, C.M. Dekaney, D.C. von Allmen, P.K. Lund, S.J. Henning, and M.A. Helmrath Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion Am J Physiol Gastrointest Liver Physiol 296 3 2009 G643 G650
14. X. Guan, B. Stoll, X. Lu, K.A. Tappenden, J.J. Holst, and B. Hartmann GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets Gastroenterology 125 1 2003 136 147 (Pubitemid 36799115)
15. L. Hansen, K.J. Hare, B. Hartmann, C.F. Deacon, R.K. Ugleholdt, and A. Plamboeck Metabolism of glucagon-like peptide-2 in pigs: role of dipeptidyl peptidase IV Regul Peptides 138 2-3 2007 126 132 (Pubitemid 46054224)
16. J. Huang, Y.F. Yang, H.F. Bian, Z.Y. Yu, J. Xu, and Z.R. Wu Rapid isolation and purification of PEGylated proteins J Northwest A & F Univ (Nat Sci Ed) 37 4 2009 191 196 (in Chinese)
17. C.P. Ivory, L.E. Wallace, D.M. McCafferty, and D.L. Sigalet Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2 Am J Physiol Gastrointest Liver Physiol 295 6 2008 G1202 G1210
18. O.B. Kinstler, N.E. Gabriel, C.E. Farrar, and R.B. De Prince N-terminally chemically modified protein composition and methods U S Pat 5985 1999 265
19. S.H. Lee, S. Lee, and S.Y. Yu Synthesis: characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1 Bioconjugate Chem 16 2 2005 377 382 (Pubitemid 40388214)
20. M.C. L'Heureux, and P.L. Brubaker Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis J Pharmacol Exp Ther 306 1 2003 347 354 (Pubitemid 36734391)
21. K. Ljungmann, B. Hartmann, P. Kissmeyer-Nielsen, A. Flyvbjerg, J.J. Holst, and S. Laurberg Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats Am J Physiol Gastrointest Liver Physiol 281 3 2001 G779 G785
22. R. Mentlein, B. Gallwitz, and W.E. Schmidt Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum Eur J Biochem 214 1993 829 835 (Pubitemid 23188160)
23. S.P. Monkarsh, C. Spence, J.E. Porter, A. Palleroni, C. Nalin, and P. Rosen Isolation of positional isomers of mono-poly(ethylene glycol)ylated interferon/α-2a and the determination of their biochemical and biological characteristics J.M. Harris, S. Zalipsky, Poly(ethylene glycol) ACS Symposium Series 680 1997 American Chemical Society Washington, DC 207 216 (Pubitemid 127444769)
24. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702 (Pubitemid 20069706)
25. N.B. Pedersen, K.R. Hjollund, A.H. Johnsen, C. Orskov, M.M. Rosenkilde, and B. Hartmann Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects Regul Peptides 146 1-3 2008 310 320
26. G. Piquet, M. Gatti, L. Barbero, S. Traversa, P. Caccia, and P. Esposito Set-up of large laboratory-scale chromatographic separations of poly(ethylene glycol) derivatives of the growth hormone-releasing factor 1-29 analogue J Chromatogr A 944 1-2 2002 141 148 (Pubitemid 34075438)
27. R.P. Boushey, B. Yusta, and D.J. Drucker Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor Cancer Res 61 2001 687 693 (Pubitemid 32128634)
28. F. Selisa, R. Schrepferb, R. Sannac, S. Scaramuzzaa, G. Tononb, and S. Dedonid Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes Results Pharm Sci 2 2012 58 65
29. D.L. Sigalet, L.E. Wallace, J.J. Holst, G.R. Martin, T. Kaji, and H. Tanaka Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2 Am J Physiol Gastrointest Liver Physiol 293 1 2007 G211 G221
30. C.H. Tsai, M. Hill, S.L. Asa, P.L. Brubaker, and D.J. Drucker Intestinal growth-promoting properties of glucagon-like peptide 2 in mice Am J Physiol 36 1997 E77 E84
31. M. Wojdemann, A. Wettergren, B. Hartmann, L. Hilsted, and J.J. Holst Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide 2 J Clin Endocrinol Metab 84 1999 2513 2517
32. Y.S. Youn, S.Y. Chae, S. Lee, J.E. Jeon, H.G. Shin, and K.C. Lee Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: insulinotropic activity, glucose-stablilizing capability, and proteolytic stability Biochem Pharmacol 73 1 2007 84 93 (Pubitemid 44853930)